Here is your NEWS-Line for Cardiovascular & Pulmonary Rehab Specialists eNewsletter. For the latest news, jobs, education and blogs, bookmark our news page and job board or to take us everywhere with you, save this link to your phone. Also, enjoy the latest issue of NEWS-Line for Healthcare Professionals magazine, always free.
NEWS:
MU Study Finds Health Benefits Of ‘Aging In Place’
The American Association of Retired Persons (AARP) found the majority of older adults want to stay in their own home as they age. However, given the natural decline in health that comes with aging, some older adults may have to move into a nursing home or assisted-living facility to receive more intensive levels of care.
To help older adults live independently as they ‘age in place,’ researchers at the University of Missouri analyzed eight years of health data from 2011 – 2019 for more than 190 residents at TigerPlace, a senior living facility developed in partnership between the MU Sinclair School of Nursing and Americare Senior Living.
Researchers found that because registered nurse care coordinators were able to identify illnesses early and quickly in residents and provide them with appropriate care and services, most of the older adults living at TigerPlace were able to stay health
Read Full Article
Established Drug For Symptoms Of Angina Pectoris Also Protects Vascular System
A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke. The study, led by MedUni Vienna and including access to data from Harvard Medical School, has now been published in the highly regarded journal "PNAS".
The complications of atherosclerosis – heart attack and stroke – are the leading causes of death in Europe and the United States. In recent years, it has been shown that chronic inflammation in the arteries leads to the formation and progression of atherosclerotic plaques (deposits in the blood vessels). The MedUni Vienna research group led by Walter Speidl (Department of Medicine II, Division of Cardiology) and Philipp Hohensinner (Center for Biomedical Research) has now demonstrated for the first time that a reduction in intracellular s
Read Full Article
ASCO22: Lung Cancer Therapy Could Help Patients Live Longer
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug combination could extend the lives of those diagnosed with advanced non-small cell lung cancer, one of the most common forms of lung cancer. The research was presented during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, with simultaneous publication in the peer-reviewed Journal of Clinical Oncology.
Currently, people diagnosed with advanced non-small cell lung cancer have limited treatment options. Therapies for the disease have improved over the past five years-including advances in immunotherapy-although even after initial tumor response, resistance develops in most tumors.
"This clinical trial shows promise in extending the lives of patients who have lung cancer that has become resistant to immunotherapy treatments," said Karen L. Rec
Read Full Article
Covid-19 Was Third Leading Cause Of Death In The United States In Both 2020 And 2021
COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute, part of the National Institutes of Health. The study appears July 5 in JAMA Internal Medicine.
During the 20-month period studied, COVID-19 accounted for 1 in 8 deaths (or 350,000 deaths) in the United States. Heart disease was the number one cause of death, followed by cancer, with these two causes of death accounting for a total of 1.29 million deaths. Accidents and stroke were the fourth and fifth leading causes of death. In every age group 15 years and older, COVID-19 was one of the top five causes of death during this period.
When the authors analyzed deaths in 2020 (March–December) and in 2021 (January–October) separately, they found that in 2020, COVID-19 was the fourth
